KB195

DRUG2 trials

Sponsors

Kaleido Biosciences

Conditions

HealthyUrea Cycle Disorder

Phase 2

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

TerminatedNCT03933410

Kaleido BiosciencesUrea Cycle Disorder

Start: 2019-09-17End: 2021-03-02Updated: 2022-01-25

Unknown Phase

A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects

CompletedNCT04603378

Kaleido BiosciencesHealthy

Start: 2017-09-18End: 2017-11-28Updated: 2020-10-26